Vlad Korobeynikov

About Vlad Korobeynikov

Vlad Korobeynikov, With an exceptional h-index of 11 and a recent h-index of 10 (since 2020), a distinguished researcher at Columbia University in the City of New York, specializes in the field of Pathology, Molecular Biology, Cell Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report

Engineered Nuclear Import Receptor Karyopherin‐β2 Chaperones Aberrant Phase Transitions of Disease‐Associated Cargo

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis

A scalable screening platform for phenotypic subtyping of ALS patient-derived fibroblasts

Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4

Therapeutic strategies targeting FUS toxicity in amyotrophic lateral sclerosis: from a novel mouse model of disease to a first-in-human study

Vlad Korobeynikov Information

University

Position

___

Citations(all)

441

Citations(since 2020)

372

Cited By

184

hIndex(all)

11

hIndex(since 2020)

10

i10Index(all)

11

i10Index(since 2020)

10

Email

University Profile Page

Google Scholar

Vlad Korobeynikov Skills & Research Interests

Pathology

Molecular Biology

Cell Biology

Top articles of Vlad Korobeynikov

Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report

Frontiers in Oncology

2024

Engineered Nuclear Import Receptor Karyopherin‐β2 Chaperones Aberrant Phase Transitions of Disease‐Associated Cargo

The FASEB Journal

2022/5

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis

Nature medicine

2022/1

A scalable screening platform for phenotypic subtyping of ALS patient-derived fibroblasts

bioRxiv

2022/9/28

Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4

Nature

2022/6/30

Therapeutic strategies targeting FUS toxicity in amyotrophic lateral sclerosis: from a novel mouse model of disease to a first-in-human study

2021

See List of Professors in Vlad Korobeynikov University(Columbia University in the City of New York)